ClinicalTrials.Veeva

Menu

A Warning Red Flag Classification System to Predict Risk of Vasovagal Syncope During Office Hysteroscopy (FLAG-VS)

T

Tanvir Hospital

Status

Invitation-only

Conditions

Vasovagal Syncope (VVS)

Treatments

Procedure: Office hysteroscopy

Study type

Observational

Funder types

Other

Identifiers

NCT07030218
TH/IEC/BHR/0154/2025/TNV/P1/V4

Details and patient eligibility

About

The goal of this pilot cross sectional study is to identify participants at risk of vasovagal reaction/syncope(VVR/VVS) during office hysteroscopy. A predictive red flag classification system is being studied to improve procedural safety during office hysteroscopy. Researchers will perform office hysteroscopy as per the standard protocol by vaginoscopic technique. A nurse positioned at the head side of the participant will record signs and symptoms of VVR/VVS. The participant will be asked of the severity of the pain experienced during office hysteroscopy in relation to their menstrual cycle. The procedure will be discontinued at any point the participant wishes to stop.

Full description

Office hysteroscopy is increasingly utilized due to advancements in instrumentation and techniques; however, its adoption in routine gynecologic practice remains limited to 10-12% of cases. This under utilization is largely attributed to the perception of pain and lack of financial incentives. Consequently, fewer than 20% of gynecologists employ office hysteroscopy for the evaluation of intrauterine pathology.

Although generally safe, vasovagal syncope (VVS) is the most concerning complication, with a reported prevalence ranging from 0.21% to 1.85%. Other complications include pain, infection, and bleeding. Surgeons often fail to anticipate vasovagal responses during the procedure. This study aims to develop a red flag classification system based on pain response to enable early recognition and prevention of VVS during office hysteroscopy.

Research design This is a multicenter, cross-sectional, analytical pilot study enrolling women undergoing office hysteroscopy over 4 months.

Sample Size Calculation Based on an estimated VVS rate of 6.3%, and using a 95% confidence interval, the sample size of 46 was calculated using Crutzen's online tool.

Statistical Analysis Descriptive analysis will be conducted for continuous and categorical variables. Chi-square tests will evaluate the association between pain classification and vasovagal events. The STROBE checklist will guide reporting.

Enrollment

46 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women ≥18 years
  • Prior gynecological care
  • Informed consent provided

Exclusion criteria

  • Inability to consent
  • Psychiatric disorders or anxiolytic use
  • Use of dilators or anesthesia above level 3a
  • Family history of VVS

Trial design

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Shobha Rathi

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems